$EFOI
ENERGY FOCUS, INC/DE Stock $efoi

$efoi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000092416823000059 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$1.055M	$930.0K
YoY Change	-28.72%	-54.88%
Cost Of Revenue	$876.0K	$913.0K
YoY Change	-36.11%	-56.25%
Gross Profit	$179.0K	$17.00K
YoY Change	64.22%	-165.38%
Gross Profit Margin	16.97%	1.83%
Selling, General & Admin	$1.132M	$1.066M
YoY Change	-42.36%	-49.88%
% of Gross Profit	632.4%	6270.59%
Research & Development	$147.0K	$154.0K
YoY Change	-58.36%	-69.38%
% of Gross Profit	82.12%	905.88%
Depreciation & Amortization	$8.000K	$8.000K
YoY Change	-81.4%	-81.82%
% of Gross Profit	4.47%	47.06%
Operating Expenses	$1.279M	$1.220M
YoY Change	-44.8%	-53.61%
Operating Profit	-$1.100M	-$1.203M
YoY Change	-50.18%	-54.71%
Interest Expense	$69.00K	$123.0K
YoY Change	-73.46%	-33.15%
% of Operating Profit
Other Income/Expense, Net	-$14.00K	-$7.000K
YoY Change	-22.22%	-36.36%
Pretax Income	-$1.167M	-$1.333M
YoY Change	-53.06%	-52.75%
Income Tax
% Of Pretax Income
Net Earnings	-$1.167M	-$1.333M
YoY Change	-53.06%	-52.75%
Net Earnings / Revenue	-110.62%	-143.33%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.42	-$0.08
COMMON SHARES
Basic Shares Outstanding	19.24M shares	18.13M shares
Diluted Shares Outstanding	2.766M shares	16.17M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.946M	$916.0K
YoY Change	35.23%	-1.08%
Cash & Equivalents	$1.316M	$301.0K
Short-Term Investments	$630.0K	$615.0K
Other Short-Term Assets	$217.0K	$226.0K
YoY Change	-74.38%	-75.14%
Inventory	$5.304M	$4.938M
Prepaid Expenses
Receivables	$841.0K	$909.0K
Other Receivables	$0.00	$445.0K
Total Short-Term Assets	$8.308M	$7.434M
YoY Change	-21.69%	-29.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.094M	$1.179M
YoY Change	-42.45%	-41.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.094M	$1.179M
YoY Change	-42.45%	-41.55%
TOTAL ASSETS
Total Short-Term Assets	$8.308M	$7.434M
Total Long-Term Assets	$1.094M	$1.179M
Total Assets	$9.402M	$8.613M
YoY Change	-24.84%	-31.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.908M	$2.177M
YoY Change	122.15%	-2.38%
Accrued Expenses	$861.0K	$841.0K
YoY Change	-33.15%	-41.43%
Deferred Revenue
YoY Change
Short-Term Debt	$284.0K	$388.0K
YoY Change	-85.66%	-87.52%
Long-Term Debt Due	$1.335M	$1.277M
YoY Change	-27.45%	9.99%
Total Short-Term Liabilities	$5.388M	$4.683M
YoY Change	-16.05%	-40.99%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities	$915.0K	$975.0K
YoY Change	-19.24%	-17.44%
Total Long-Term Liabilities	$915.0K	$975.0K
YoY Change	-52.37%	-17.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.388M	$4.683M
Total Long-Term Liabilities	$915.0K	$975.0K
Total Liabilities	$6.303M	$5.658M
YoY Change	-24.42%	-37.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.5M	-$150.4M
YoY Change	5.19%	6.21%
Common Stock	$154.6M	$153.3M
YoY Change	4.32%	5.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.099M	$2.955M
YoY Change
Total Liabilities & Shareholders Equity	$9.402M	$8.613M
YoY Change	-24.84%	-31.37%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.167M	-$1.333M
YoY Change	-53.06%	-52.75%
Depreciation, Depletion And Amortization	$8.000K	$8.000K
YoY Change	-81.4%	-81.82%
Cash From Operating Activities	-$152.0K	-$1.200M
YoY Change	-94.25%	-55.6%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.167M	$1.432M
YoY Change	-65.24%	409.61%
NET CHANGE
Cash From Operating Activities	-$152.0K	-$1.200M
Cash From Investing Activities	$0.00	$0.00
Cash From Financing Activities	$1.167M	$1.432M
Net Change In Cash	$1.015M	$249.0K
YoY Change	42.36%	-110.13%
FREE CASH FLOW
Cash From Operating Activities	-$152.0K	-$1.200M
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$152.0K	-$1.200M
YoY Change	-94.25%	-56.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000924168
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ENERGY FOCUS, INC/DE
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36583
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3021850
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	32000 Aurora Road
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Solon
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44139
CY2023Q1	dei	City Area Code CityAreaCode	(440)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	715-1300
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	EFOI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19243610	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	301000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	909000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	445000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4938000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5476000	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	615000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	592000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	226000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	232000	usd
CY2023Q1	efoi	Receivable For Claimed Employee Retention Tax Credit Current ReceivableForClaimedEmployeeRetentionTaxCreditCurrent	445000	usd
CY2022Q4	efoi	Receivable For Claimed Employee Retention Tax Credit Current ReceivableForClaimedEmployeeRetentionTaxCreditCurrent	445000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	7434000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7242000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	68000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	76000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1111000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1180000	usd
CY2023Q1	us-gaap	Assets Assets	8613000	usd
CY2022Q4	us-gaap	Assets Assets	8498000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2177000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2204000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	229000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145000	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	235000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	261000	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	29000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	76000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	143000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	183000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	205000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	198000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	388000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1447000	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	814000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1277000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2618000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4683000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7946000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	975000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1029000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5658000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8975000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	876447	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	876447	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	876447	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	876447	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19243610	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19243610	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9848438	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9848438	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	153311000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	148545000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150355000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149020000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2955000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-477000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8613000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8498000	usd
CY2023Q1	us-gaap	Revenues Revenues	930000	usd
CY2022Q1	us-gaap	Revenues Revenues	2061000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	913000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2087000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	17000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-26000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	154000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	503000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1066000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2127000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1220000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2630000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1203000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2656000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	123000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	184000	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30000	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	7000	usd
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	11000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1333000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2821000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.44
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.44
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16172000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16172000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6437000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6437000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-477000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3025000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	1716000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1333000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2955000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6209000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2821000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3432000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1333000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2821000	usd
CY2023Q1	efoi	Gain Loss From Employee Retention Tax Credit GainLossFromEmployeeRetentionTaxCredit	0	usd
CY2022Q1	efoi	Gain Loss From Employee Retention Tax Credit GainLossFromEmployeeRetentionTaxCredit	30000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	8000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	44000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	26000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	44000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-9000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	-23000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	129000	usd
CY2023Q1	efoi	Increase Decrease In Provision For Warranties IncreaseDecreaseInProvisionForWarranties	-40000	usd
CY2022Q1	efoi	Increase Decrease In Provision For Warranties IncreaseDecreaseInProvisionForWarranties	-30000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	62000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	69000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	496000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	83000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-562000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-370000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	23000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-12000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	61000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	66000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-211000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-268000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	150000	usd
CY2022Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	118000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1183000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2703000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35000	usd
CY2023Q1	efoi	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	3025000	usd
CY2022Q1	efoi	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	-1093000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	897000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1432000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	281000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	249000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2457000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2682000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	301000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	NATURE OF<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPERATIONS</span>Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient lighting systems and controls. We develop, market and sell high quality light-emitting diode (“LED”) lighting and controls products in the commercial market and military maritime market (“MMM”), and began to expand our offerings into the consumer market in the fourth quarter of 2021. Our mission is to enable our customers to run their facilities, offices with greater energy efficiency, productivity, and human health and wellness through advanced LED retrofit solutions. Our goal is to be the human wellness lighting and LED technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military-grade tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial and consumer applications. We are also evaluating adjacent technologies, including Gallium Nitride (“GaN”) based power supplies and additional market opportunities for energy solution products that support sustainability in our existing channels.
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1300000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10300000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1200000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6700000	usd
CY2023Q1	efoi	Common Stock Minimum Bid Price CommonStockMinimumBidPrice	1.00
CY2023Q1	efoi	Common Stock Trade Price Per Share CommonStockTradePricePerShare	1.00
CY2023Q1	efoi	Common Stock Minimum Bid Price CommonStockMinimumBidPrice	1.00
CY2022Q3	efoi	Common Stock Closing Bid Price Threshold CommonStockClosingBidPriceThreshold	1.00
CY2022Q3	efoi	Number Of Consecutive Days For Bid Price Below Threshold NumberOfConsecutiveDaysForBidPriceBelowThreshold	30	d
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2500000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1500000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact us in the future, actual results may vary from the estimates. Estimates include, but are not limited to, the establishment of reserves for accounts receivable, sales returns, inventory obsolescence and warranty claims; the useful lives of property and equipment; valuation allowance for net deferred taxes; and stock-based compensation. The Company began using estimates for its calculation of impairment to accounts receivable under Accounting Standards Codification (“ASC”) 326 commencing in 2023. In addition, estimates and assumptions associated with the determination of the fair value of financial instruments and evaluation of long-lived assets for impairment requires considerable judgment. Actual results could differ from those estimates and such differences could be material.</span></div>
CY2023Q1	us-gaap	Revenues Revenues	930000	usd
CY2022Q1	us-gaap	Revenues Revenues	2061000	usd
CY2023Q1	efoi	Contract With Customer Payment Terms ContractWithCustomerPaymentTerms	P30D
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	967000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	471000	usd
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1337000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	909000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	445000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1330000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1333000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2821000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16172000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16172000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6437000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6437000	shares
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	183000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	295000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	-1000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	-1000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-39000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-15000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	0	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	14000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	143000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	265000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain risks and concentrations</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a distributor to the U.S. Department of Defense, accounted for approximately 22%, 27%, and 11% of net sales, respectively. When sales for our top military customers are combined, total net sales of military products comprised approximately 49% of net sales for the same period. For the three months ended March 31, 2022, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a commercial building systems provider, accounted for approximately 15%, 21%, and 19% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 37% of net sales for the same period.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a distributor to the U.S. Department of Defense, accounted for approximately 32%, 22%, and 17% of net trade accounts receivable, respectively, at March 31, 2023. At December 31, 2022, a distributor to the U.S. Department of Defense accounted for 25% of our net trade accounts receivable, and when combined with our net trade accounts receivable to shipbuilders for the U.S. Navy, total net accounts receivable related to U.S. Navy sales is 30% of our net trade accounts receivable.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No one supplier accounted for more than 10% of our total expenditures for the three months ended March 31, 2023. For the three months ended March 31, 2022, one offshore supplier accounted for approximately 19% of total expenditures.</span></div>At March 31, 2023 and December 31, 2022, one offshore supplier accounted for approximately 36% of our trade accounts payable balance.
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2936000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3347000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4509000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4656000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2507000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2527000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4938000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5476000	usd
CY2022Q4	efoi	Inventory Valuation Reserves Raw Materials InventoryValuationReservesRawMaterials	2527000	usd
CY2021Q4	efoi	Inventory Valuation Reserves Raw Materials InventoryValuationReservesRawMaterials	3050000	usd
CY2023Q1	efoi	Inventory Valuation Reserves Provision Accrual InventoryValuationReservesProvisionAccrual	-56000	usd
CY2022Q1	efoi	Inventory Valuation Reserves Provision Accrual InventoryValuationReservesProvisionAccrual	-145000	usd
CY2023Q1	efoi	Inventory Valuation Reserves Sales Of Inventory InventoryValuationReservesSalesOfInventory	76000	usd
CY2022Q1	efoi	Inventory Valuation Reserves Sales Of Inventory InventoryValuationReservesSalesOfInventory	16000	usd
CY2023Q1	efoi	Inventory Valuation Reserves Raw Materials InventoryValuationReservesRawMaterials	2507000	usd
CY2022Q1	efoi	Inventory Valuation Reserves Raw Materials InventoryValuationReservesRawMaterials	3179000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1392000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1392000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1324000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1316000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	68000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	76000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	8000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	44000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0725
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	25000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	117000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	132000	usd
CY2023Q1	efoi	Operating Lease Cost Net Of Sublease Income OperatingLeaseCostNetOfSubleaseIncome	117000	usd
CY2022Q1	efoi	Operating Lease Cost Net Of Sublease Income OperatingLeaseCostNetOfSubleaseIncome	107000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1111000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1180000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1180000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1227000	usd
CY2023Q1	efoi	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	13000	usd
CY2022Q4	efoi	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	13000	usd
CY2023Q1	efoi	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	13000	usd
CY2022Q4	efoi	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	13000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	385000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	379000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	387000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	391000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	99000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1641000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	461000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1180000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	95000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	136000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1000	usd
CY2020Q3	efoi	Debt Instrument Number Of Credit Facilities DebtInstrumentNumberOfCreditFacilities	2	creditfacility
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9200000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9600000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	37500000	usd
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q1	efoi	Percentage Of Series A Preferred Stock Eligible To Vote PercentageOfSeriesAPreferredStockEligibleToVote	0.1107
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	144000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	285000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	330808	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.97
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	65903	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.88
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	264905	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.75
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	218307	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.87
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	66734	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.10
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	1391000	usd
CY2021Q3	efoi	Payroll Tax Credit Employee Retention Credit Under The Cares Act PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESAct	431000	usd
CY2021Q2	efoi	Payroll Tax Credit Employee Retention Credit Under The Cares Act Current PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent	445000	usd
CY2022Q4	efoi	Payroll Tax Credit Employee Retention Credit Under The Cares Act Current PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent	445000	usd
CY2023Q1	efoi	Payroll Tax Credit Employee Retention Credit Under The Cares Act Current PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent	445000	usd

Files In Submission

Name	View Source	Status
efoi-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0000924168-23-000059-index-headers.html	Edgar Link	pending
0000924168-23-000059-index.html	Edgar Link	pending
0000924168-23-000059.txt	Edgar Link	pending
0000924168-23-000059-xbrl.zip	Edgar Link	pending
a20230331exh1010xefoimarch.htm	Edgar Link	pending
a20230331exh109xefoimarch2.htm	Edgar Link	pending
a20230331exhibit31110-q.htm	Edgar Link	pending
a20230331exhibit32110-q.htm	Edgar Link	pending
efoi-20230331.htm	Edgar Link	pending
efoi-20230331.xsd	Edgar Link	pending
efoi-20230331_def.xml	Edgar Link	unprocessable
efoi-20230331_lab.xml	Edgar Link	unprocessable
efoi-20230331_pre.xml	Edgar Link	unprocessable
efoi-20230331_htm.xml	Edgar Link	completed
exh1011streetervile2023-03.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EFOI
ENERGY FOCUS, INC/DE Stock $efoi

2023 Q2 Form 10-Q Financial Statement

#000092416823000059 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFOI ENERGY FOCUS, INC/DE Stock $efoi

2023 Q2 Form 10-Q Financial Statement

#000092416823000059 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFOI
ENERGY FOCUS, INC/DE Stock $efoi